Michael Linnebacher - Concepedia

Author

Michael Linnebacher

Also Known As

Ahmet Hacimuftuoglu, Linnebacher, Michael, M Linnebacher, M. Linnebacher, MICHAEL LINNEBACHER, Michael Linnebacher, Michael Linnebacher (180341), Michael Linnebacher(New Corresponding Author)

330

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

University of Rostock Heidelberg University German Cancer Research Center Johannes Gutenberg University Mainz University Medical Center of the Johannes Gutenberg University Mainz

About

Michael Linnebacher is an author at University of Rostock specializing in medicine, immunology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	37	1.7K
2	Engineering	4	4	160
3	Health Sciences	2	2	68
4	Natural Sciences	1	1	48
5	Allergy	1	1	10

Michael Linnebacher

100

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers Yvette Schwitalle, Matthias Kloor, Susanne Eiermann, Gastroenterology ImmunogeneticsAutoimmune DiseaseDisease MechanismHnpcc PatientsImmunology	2008	375
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets Enzo Médico, Mariangela Russo, Gabriele Picco, Nature Communications	2015	299
A global assessment of recent trends in gastrointestinal cancer and lifestyle‐associated risk factors Lili Lu, Christina Susanne Mullins, Clemens Schafmayer, Cancer Communications	2021	276
Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens Michael Linnebacher, Johannes Gebert, W. Rudy, International Journal of Cancer	2001	230
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells Robert Ramer, Katharina Heinemann, Jutta Merkord, Molecular Cancer Therapeutics Tumor BiologyCox-2 MrnaCox-2 InhibitorLung InflammationMedicine	2012	198
Cannabidiol inhibits lung cancer cell invasion and metastasis <i>via</i> intercellular adhesion molecule‐1 Robert Ramer, Katharina Bublitz, Nadine Freimuth, The FASEB Journal	2011	162
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in <i>BRAF</i> -Mutant Colorectal Cancer Daniele Oddo, Erin M. Sennott, Ludovic Barault, Cancer Research	2016	119
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin Sabrina Arena, Giorgio Corti, Erika Durinikova, Clinical Cancer Research	2019	108
Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1 Maria Haustein, Robert Ramer, Michael Linnebacher, Biochemical Pharmacology Cannabis UseCancer ImmunosurveillanceMedicineImmunologyCell Death	2014	100
Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells. Yvette Schwitalle, Michael Linnebacher, Eva Ripberger, PubMed EngineeringImmunologyImmunogenic PeptidesTumor BiologyFrameshift Peptides	2004	93

Page 1